Julie B. Feder
2020 - Aura Biosciences
In 2020, Julie B. Feder earned a total compensation of $552.3K as Chief Financial Officer at Aura Biosciences.
Compensation breakdown
| Bonus | $113,249 |
|---|---|
| Option Awards | $95,877 |
| Salary | $343,216 |
| Total | $552,342 |
Feder received $343.2K in salary, accounting for 62% of the total pay in 2020.
Feder also received $113.2K in bonus and $95.9K in option awards.
Rankings
In 2020, Julie B. Feder's compensation ranked 10,739th out of 13,090 executives tracked by ExecPay. In other words, Feder earned more than 18.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,739 out of 13,090 | 18th |
Division Manufacturing | 4,590 out of 5,621 | 18th |
Major group Chemicals And Allied Products | 1,904 out of 2,254 | 16th |
Industry group Drugs | 1,669 out of 1,954 | 15th |
Industry Biological Products, Except Diagnostic Substances | 376 out of 411 | 9th |
Source: SEC filing on April 28, 2022.
Feder's colleagues
We found two more compensation records of executives who worked with Julie B. Feder at Aura Biosciences in 2020.